gm albumin dl serum plasma neratinib uln trametinib mg subjects 
leukocytes mcl days registration phase obtained initiation ii treatment prior 
albumin dl days registration prior obtained serum study treatment mg 
albumin dl serum arm decreased cohort prothrombin range unless equal 
hemoglobin registration dl obtained days prior mg creatinine step study 
calcium mg registration dl days corrected serum step documented prior 
prestudy physical obtained registration history days prior exam pre study 
performed albumin initiation dl mg days treatment hemoglobin registration dehydration 
hgb hemoglobin dl registration obtained days prior treatment study protocol 
albumin mg dl supplementation serum intravenous day cycle days hypercalcemia 
cabozantinib prior treatment dose days dl albumin platelets obtained hemoglobin 
albumin initiation dl mg days treatment cohort sbrt noted determined 
